These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19914658)

  • 1. Effects of silodosin and naftopidil on the distal ureter and cardiovascular system in anesthetized dogs: comparison of potential medications for distal ureteral stone passage.
    Kobayashi S; Tomiyama Y; Hoyano Y; Yamazaki Y; Sasaki S; Kohri K
    J Urol; 2010 Jan; 183(1):357-61. PubMed ID: 19914658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of silodosin on intraurethral pressure increase induced by hypogastric nerve stimulation in dogs with benign prostatic hyperplasia].
    Tomiyama Y; Tatemichi S; Tadachi M; Kobayashi S; Hayashi M; Kobayashi M; Yamazaki Y; Shibata N
    Yakugaku Zasshi; 2006 Mar; 126 Spec no.():225-30. PubMed ID: 16518087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of silodosin (KMD-3213) on phenylephrine-induced increase in intraurethral pressure and blood pressure in rats--study of the selectivity for lower urinary tract].
    Tatemichi S; Kobayashi K; Maruyama I; Kobayashi M; Yamazaki Y; Shibata N
    Yakugaku Zasshi; 2006 Mar; 126 Spec no.():217-23. PubMed ID: 16518086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uroselectivity in male dogs of silodosin (KMD-3213), a novel drug for the obstructive component of benign prostatic hyperplasia.
    Tatemichi S; Tomiyama Y; Maruyama I; Kobayashi S; Kobayashi K; Maezawa A; Kobayashi M; Yamazaki Y; Shibata N
    Neurourol Urodyn; 2006; 25(7):792-9; discussion 800-1. PubMed ID: 16894620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naftopidil vs silodosin in medical expulsive therapy for ureteral stones: a randomized controlled study in Japanese male patients.
    Tsuzaka Y; Matsushima H; Kaneko T; Yamaguchi T; Homma Y
    Int J Urol; 2011 Nov; 18(11):792-5. PubMed ID: 21917021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silodosin to facilitate passage of ureteral stones: a multi-institutional, randomized, double-blinded, placebo-controlled trial.
    Sur RL; Shore N; L'Esperance J; Knudsen B; Gupta M; Olsen S; Shah O
    Eur Urol; 2015 May; 67(5):959-64. PubMed ID: 25465978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: Naftopidil vs silodosin in medical expulsive therapy for ureteral stones: a randomized controlled study in Japanese male patients.
    Söylemez H; Bodakci MN; Hatipoglu NK
    Int J Urol; 2012 Aug; 19(8):792; author reply 792-3. PubMed ID: 22435593
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanical function and gene expression of alpha(1)-adrenoceptor subtypes in dog intravesical ureter.
    Kobayashi S; Tomiyama Y; Hoyano Y; Yamazaki Y; Kusama H; Kubota Y; Sasaki S; Kohri K
    Urology; 2009 Aug; 74(2):458-62. PubMed ID: 19371927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naftopidil, a novel alpha1-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human alpha1-adrenoceptors.
    Takei R; Ikegaki I; Shibata K; Tsujimoto G; Asano T
    Jpn J Pharmacol; 1999 Apr; 79(4):447-54. PubMed ID: 10361884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of silodosin and tamsulosin on the urethra and cardiovascular system in young and old dogs with benign prostatic hyperplasia.
    Kobayashi S; Tomiyama Y; Tatemichi S; Hoyano Y; Kobayashi M; Yamazaki Y
    Eur J Pharmacol; 2009 Jun; 613(1-3):135-40. PubMed ID: 19389393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo study on the effects of alpha1-adrenoceptor antagonists on intraurethral pressure in the prostatic urethra and intraluminal pressure in the vas deferens in male dogs.
    Noguchi Y; Ohtake A; Suzuki M; Sasamata M
    Eur J Pharmacol; 2008 Feb; 580(1-2):256-61. PubMed ID: 18078926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of selective alpha1D-blocker naftopidil as medical expulsive therapy for distal ureteral stones.
    Sun X; He L; Ge W; Lv J
    J Urol; 2009 Apr; 181(4):1716-20. PubMed ID: 19233432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing efficacy of α1D-receptor antagonist naftopidil and α1A/D-receptor antagonist tamsulosin in management of distal ureteral stones.
    Zhou SG; Lu JL; Hui JH
    World J Urol; 2011 Dec; 29(6):767-71. PubMed ID: 21845472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Naftopidil in the Medical Expulsion Therapy for Distal Ureteral Stone: A Systematic Review and Meta-Analysis.
    Li J; Tang Z; Gao L; Li J; Qin F; Yuan J
    J Endourol; 2017 May; 31(5):427-437. PubMed ID: 28306333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of four different alpha(1)-adrenoceptor antagonists on alpha-adrenoceptor agonist-induced contractions in isolated mouse and hamster ureters.
    Kobayashi S; Tomiyama Y; Maruyama K; Hoyano Y; Yamazaki Y; Kusama H
    J Smooth Muscle Res; 2009 Aug; 45(4):187-95. PubMed ID: 19783871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of prophylactic naftopidil, tamsulosin, and silodosin for 125I brachytherapy-induced lower urinary tract symptoms in patients with prostate cancer: randomized controlled trial.
    Tsumura H; Satoh T; Ishiyama H; Tabata K; Kotani S; Minamida S; Kimura M; Fujita T; Matsumoto K; Kitano M; Hayakawa K; Baba S
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e385-92. PubMed ID: 21664068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of silodosin and naftopidil in the treatment of bladder dysfunction in the spontaneously hypertensive rat.
    Saito M; Shimizu S; Ohmasa F; Oikawa R; Tsounapi P; Dimitriadis F; Kinoshita Y; Satoh K
    Neurourol Urodyn; 2013 Apr; 32(4):393-8. PubMed ID: 22907830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naftopidil versus flopropione as medical expulsive therapy for distal ureteral stones: results of a randomized, multicenter, double-blind, controlled trial.
    Kohjimoto Y; Hagino K; Ogawa T; Inagaki T; Kitamura S; Nishihata M; Iba A; Matsumura N; Hara I
    World J Urol; 2015 Dec; 33(12):2125-9. PubMed ID: 25869815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silodosin versus naftopidil in the treatment of premature ejaculation: A prospective multicenter trial.
    Sato Y; Otani T; Amano T; Araki T; Kondou N; Matsukawa M; Tobe M; Haga K; Uchida K; Honma I
    Int J Urol; 2017 Aug; 24(8):626-631. PubMed ID: 28627033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacological properties of naftopidil, a drug for treatment of the bladder outlet obstruction for patients with benign prostatic hyperplasia].
    Ikegaki I
    Nihon Yakurigaku Zasshi; 2000 Aug; 116(2):63-9. PubMed ID: 10976457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.